Overview

Etanercept for the Treatment of Chronic Urticaria

Status:
Withdrawn

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of etanercept for patients with chronic idiopathic urticaria unresponsive to antihistamines.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University of Utah

Treatments:

Etanercept